|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Non-affiliated/non-control investments (cost: $386,379,336 and $390,403,599, respectively) | ||||||||||||||||
| Non-affiliated/non-control investments | ||||||||||||||||
| Affiliated investments | ||||||||||||||||
| Total non-affiliated/non-control investments (cost: $386,379,336 and $390,403,599, respectively) | ||||||||||||||||
| Affiliated investments (cost: $16,836,822 and $16,836,822, respectively) | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Securities sold, not settled | ||||||||||||||||
| Unsettled repayment of principal | ||||||||||||||||
| Cash equivalents (cost of $32,770,267 and $51,236,068, respectively) | ||||||||||||||||
| Cash | ||||||||||||||||
| Interest and distributions receivable | ||||||||||||||||
| Securities sold not settled | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES | ||||||||||||||||
| Notes payable | ||||||||||||||||
| Notes Payable Six Five Zero | ||||||||||||||||
| Notes payable – 6.25% | ||||||||||||||||
| Notes payable – 5.50% | ||||||||||||||||
| Notes payable – 7.75% | ||||||||||||||||
| Accrued interest payable | ||||||||||||||||
| Base Fee and Net Investment Income Incentive Fee payable to affiliate | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Accrued expenses | ||||||||||||||||
| Securities purchased not settled | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| NET ASSETS | ||||||||||||||||
| Common stock, $0.01 par value, 300,000,000 shares authorized; 105,058,242 and 86,060,964 shares issued and outstanding, respectively | ||||||||||||||||
| Capital in excess of par value | ||||||||||||||||
| Total distributable earnings/(accumulated losses) | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| Net asset value per common share (in Dollars per share) | ||||||||||||||||
Loading...
